Guanfacine hydrochloride

CAS No. 29110-48-3

Guanfacine hydrochloride ( Guanfacine )

Catalog No. M13896 CAS No. 29110-48-3

A selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 42 In Stock
25MG 70 In Stock
50MG 126 In Stock
100MG 203 In Stock
200MG 311 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Guanfacine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone.
  • Description
    A selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone; a sympatholytic agent used to treat hypertension and attention deficit hyperactivity disorder (ADHD).Hypertension Approved
  • Synonyms
    Guanfacine
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    α2A-adrenoceptor
  • Research Area
    Cardiovascular Disease
  • Indication
    Hypertension

Chemical Information

  • CAS Number
    29110-48-3
  • Formula Weight
    282.55
  • Molecular Formula
    C9H10Cl3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 30 mg/mL
  • SMILES
    Cl.NC(N)=NC(=O)CC1=C(Cl)C=CC=C1Cl
  • Chemical Name
    Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, hydrochloride (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Midodrine hydrochlor...

    Midodrine is a selective α1-adrenoceptor agonist that acts as a vasopressor/antihypotensive agent for the treatment of dysautonomia and orthostatic hypotension.

  • ARC 239 dihydrochlor...

    A potent, selective α2B adrenoceptor antagonist with pKd of 8.8, 200-fold selectivity over α2A, and α2D receptors.

  • Dabuzalgron

    Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.